Journals / Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi / 2012 / Cilt: 25 - Sayı: 3

Majör depresif bozukluk ve yaygın anksiyete bozukluğunda malondialdehid ve E vitamini düzeyleri

Altered levels of malondialdehyde and vitamin e in major depressive disorder and generalized anxiety disorder

Pages
206–211
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, free radical damage and deficiency of antioxidant defence systems may have an important role in major depressive disorder and generalized anxiety disorder.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Altered levels of malondialdehyde and vitamin E in major depressive disorder and generalized anxiety disorder Introduction: Reactive oxygen species (ROS) may play a role in some neuropsychiatric disorders.
📊
Key Findings & Data:There is some evidence that the activation of immune-inflammatory processes, an increase in monoamines catabolism and abnormalities in lipid compounds may cause overproduction of ROS and lipid peroxidation.
💡
Conclusion & Impact:As a result, free radical damage and deficiency of antioxidant defence systems may have an important role in major depressive disorder and generalized anxiety disorder.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Altered levels of malondialdehyde and vitamin E in major depressive disorder and generalized anxiety disorder Introduction: Reactive oxygen species (ROS) may play a role in some neuropsychiatric disorders. There is some evidence that the activation of immune-inflammatory processes, an increase in monoamines catabolism and abnormalities in lipid compounds may cause overproduction of ROS and lipid peroxidation. These phenomena may be related to pathophysiology of major depressive disorder and generalized anxiety disorder. Malondialdehyde (MDA) is the end product of lipid peroxidation. Vitamin E is thought to play an important role as an antioxidant against lipid peroxidation. This study aims to investigate the role of oxygen radicals in the etiology of major depressive disorder and generalized anxiety disorder. Method: Plasma MDA and vitamin E levels of patients with major depressive disorder (n=42) and generalized anxiety disorder (n=37) were compared with healthy controls (n=38). To assess depressive symptoms and anxiety symptoms, Hamilton Depression Scale and Hamilton Anxiety Scale were applied. Results: Patients with major depressive disorder and generalized anxiety disorder had higher MDA and lower vitamin E levels than those of healthy controls. Differences between the patient and the control groups according to these two parameters were found statistically significant. Conclusion: Our results support the hypothesis that oxidative stress may affect depressive and anxiety symptoms. As a result, free radical damage and deficiency of antioxidant defence systems may have an important role in major depressive disorder and generalized anxiety disorder.

Özet

Amaç: Reaktif oksijen türleri (ROT) bazı nöropsikiyatrik rahatsızlıklarda rol oynayabilirler. İmmün-inflamatuvar aktivasyon, monoamin katabolizmasında artış ve lipid bileşenlerinde ortaya çıkan anormalliklerin aşırı ROT üretimine ve lipid peroksidasyonuna neden olduğuna dair kanıtlar bulunmaktadır. Bu fenomenler, majör depresyon ve yaygın anksiyete bozukluğunun patofizyolojisi ile ilişkili olabilir. Malondialdehid (MDA) lipid peroksidasyonunun son ürünüdür. E vitamininin lipid peroksidasyonuna karşı önemli bir antioksidan molekül olduğu ileri sürülmektedir. Bu çalışmanın amacı, oksijen radikallerinin majör depresif bozukluk ve yaygın anksiyete bozukluğunun etiyolojisindeki rolünü belirlemektir. Yöntem: Majör depresif bozukluk tanısı alan 42 hasta ve yaygın anksiyete bozukluğu tanısı (YAB) alan 37 hasta ile sağlıklı kontrol grubunu oluşturan 38 kişinin plazma MDA ve E vitamini düzeyleri ölçüldü. Tüm gruplara Hamilton Depresyon Ölçeği (HDÖ) ve Hamilton Anksiyete Ölçeği (HAÖ) uygulandı. Bulgular: Majör depresif bozukluk ve yaygın anksiyete bozukluğu tanısı alan kişilerin, sağlıklı kontrol grubuna kıyasla daha yüksek MDA ve daha düşük E vitamini düzeylerine sahip oldukları saptandı. Hasta ve kontrol grupları arasındaki fark istatistiksel olarak anlamlı bulundu. Sonuç: Bulgularımız oksidatif stresin depresyon ve anksiyete semptomlarında etkili olabileceğini desteklemektedir. Sonuç olarak, serbest radikal hasarı ve antioksidan savunma sistemindeki yetersizlik majör depresif bozukluk ve yaygın anksiyete bozukluğunun etiyolojisinde önemli rol alabilir.

🔖

Cite This Article

BAL, N., TOT, Ş. A., YAZICI, A., YAZICI, K., TAMER, L. (2012). Majör depresif bozukluk ve yaygın anksiyete bozukluğunda malondialdehid ve E vitamini düzeyleri. Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi, Cilt: 25 - Sayı: 3, 206–211. https://ajindex.com/articles/214519

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lohr JB. Oxygen radicals and neuropsychiatric illnesses. Some speculations. Arch Gen Psychiatry 1991; 48:1097-1104
  2. Torun M, Yardım S, Gönenç A, Sargın H. Çeşitli kanser vakalarında serum MDA düzeyleri. Biyokimya Dergisi 1995; 20:1-7. (Article in Turkish
  3. Draper H, McGirr LG, Hadley M. The metabolism of malondialdehyde. Lipids 1986; 21:305-307
  4. Rigucci S, Serafini G, Pompili M, Kotzalidis GD, Tatarelli R. Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies. World J Biol Psychiatry 2010; 11:165-180
  5. Jesperger JA. Oxygen free radicals and brain function. Int J Neurosci 1991; 57:1-17
  6. Weber GF. The pathopsysiology of reactive oxygen intermediates in the central nervous system. Med Hypothesis 1994; 43:223- 230
  7. Sarandol A, Sarandol E, Eker SS, Erdinç S, Vatansever E, Kırlı S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative- antioxidative systems. Hum Psychopharmacol 2007; 22:67-73
  8. Özcan E, Güleç M, Özerol E, Polat R, Akyol Ö. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004; 19:89-95
  9. Galecki P, Szemraj J, Bienkiewicz M, Zboralski K, Galecka E. Oxidatif stress parameters after combined fluoxetine and acetylsalisilic acid therapy in depressive patients. Hum Psychopharmacol 2009; 24:277-286
  10. Irwin M. Immun correlates of depression. Adv Exp Med Biol 1999; 461:1-24
  11. Maddock C, Pariante CM. How does stres affect you? An overview of stres, immunity, depression and disease. Epidemiol Psychiatr Soc 2001; 10:153-162
  12. Maes M, De Vos N, Pioli R, Wauters A, Neels H, Cristophe A. Lower serum vitamin E concentrations in major depression: another marker of lowered antioxidant defences in that illness. J Affect Disord 2000; 58:241-246
  13. Maes M, Smith RS. Fatty acids, cytokines and major depression. Biol Psychiatry 1998; 43:313-314
  14. Maes M, Cristophe A, Delange J, Neels H, Scharpe S, Meltzer HY. Lowered omega 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1996; 85:275-291
  15. Mathew SJ, Mao X, Keegan KA, Levine SM, Smith ELP, Heier LA, Otcheretko V, Coplan JD, Shungu DC. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T 1 H MRS imaging study. NMR Biomed 2009; 251-258
  16. Kuloglu M, Atmac